147 related articles for article (PubMed ID: 23063839)
1. Rubella seroprevalence in the first birth cohort reaching fertility age after 20 years of two dose universal vaccination policy in Israel.
Levine H; Ankol OE; Rozhavski V; Davidovitch N; Aboudy Y; Zarka S; Balicer RD
Vaccine; 2012 Nov; 30(50):7260-4. PubMed ID: 23063839
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of measles, mumps and rubella among young adults, after 20 years of universal 2-dose MMR vaccination in Israel.
Levine H; Zarka S; Ankol OE; Rozhavski V; Davidovitch N; Aboudy Y; Balicer RD
Hum Vaccin Immunother; 2015; 11(6):1400-5. PubMed ID: 25891446
[TBL] [Abstract][Full Text] [Related]
3. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
4. Seroprevalence of measles and rubella antibodies in pregnant women Haiti, 2012.
Fitter DL; Anselme R; Paluku G; Rey G; Flannery B; Tohme RA; Marston BJ; Griswold M; Boncy J; Vertefeuille JF
Vaccine; 2013 Dec; 32(1):69-73. PubMed ID: 24188751
[TBL] [Abstract][Full Text] [Related]
5. Rubella seroprevalence among young women taipei county after routine measles, mumps and rubella immunization program.
Wang IJ; Hwang KC; Tsai YH; Wu YN; Chao SJ; Chen TE; Huang LM
Acta Paediatr Taiwan; 2006; 47(1):14-7. PubMed ID: 17016964
[TBL] [Abstract][Full Text] [Related]
6. Use of rubella seroepidemiological data for assessment of previous vaccination policy and for decision making in response to epidemics in Israel.
Cohen D; Muhsen Kh; Aboudy Y; Harari H; Mendelson E; Green MS
Vaccine; 2006 Jul; 24(27-28):5604-8. PubMed ID: 16716460
[TBL] [Abstract][Full Text] [Related]
7. Are we hitting immunity targets? The 2006 age-specific seroprevalence of measles, mumps, rubella, diphtheria and tetanus in Belgium.
Theeten H; Hutse V; Hens N; Yavuz Y; Hoppenbrouwers K; Beutels P; Vranckx R; Van Damme P
Epidemiol Infect; 2011 Apr; 139(4):494-504. PubMed ID: 20587123
[TBL] [Abstract][Full Text] [Related]
8. Declining seroprevalence of rubella antibodies among young Israeli adults: a 12-year comparison.
Huerta M; Davidovitch N; Ankol OE; Zaaide Y; Grotto I; Balicer RD; Zangvil E
Prev Med; 2004 Dec; 39(6):1223-6. PubMed ID: 15539059
[TBL] [Abstract][Full Text] [Related]
9. Humoral and cellular immune response after measles vaccination in Taiwan.
Huang CL; Yang YH; Wang LC; Lin YT; Tsai YY; Chiang BL
J Microbiol Immunol Infect; 2005 Jun; 38(3):169-75. PubMed ID: 15986066
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.
Gohil DJ; Kothari ST; Chaudhari AB; Gunale BK; Kulkarni PS; Deshmukh RA; Chowdhary AS
Viral Immunol; 2016 Apr; 29(3):159-63. PubMed ID: 26910764
[TBL] [Abstract][Full Text] [Related]
11. Residual susceptibility to measles among young adults in Victoria, Australia following a national targeted measles-mumps-rubella vaccination campaign.
Kelly HA; Gidding HF; Karapanagiotidis T; Leydon JA; Riddell MA
BMC Public Health; 2007 Jun; 7():99. PubMed ID: 17555601
[TBL] [Abstract][Full Text] [Related]
12. Seroepidemiology study of rubella antibodies among pregnant women from seven Asian countries: evaluation of the rubella vaccination program in Taiwan.
Tseng HF; Chang CK; Tan HF; Yang SE; Chang HW
Vaccine; 2006 Jul; 24(29-30):5772-7. PubMed ID: 16759764
[TBL] [Abstract][Full Text] [Related]
13. Serosurvey of measles, mumps and rubella antibodies in Saudi children.
Al-Mazrou YY; Khalil MK; Tischer A; Al-Jeffri MH; Al-Ghamdi YS; Bakhsh MM; Mishkas AA; Elgizouli SA
Saudi Med J; 2005 Oct; 26(10):1551-4. PubMed ID: 16228054
[TBL] [Abstract][Full Text] [Related]
14. Measles-mumps-rubella revaccination; 18 months vs. 4-6 years of age: potential impacts of schedule changes.
Saffar MJ; Fathpour GR; Parsaei MR; Ajami A; Khalilian AR; Shojaei J; Saffar H
J Trop Pediatr; 2011 Oct; 57(5):347-51. PubMed ID: 21078605
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
Sultana R; Rahman MM; Hassan Z; Hassan MS
Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
[TBL] [Abstract][Full Text] [Related]
16. Response to third rubella vaccine dose.
Siira L; Nøkleby H; Barlinn R; Riise ØR; Aaberge IS; Dudman SG
Hum Vaccin Immunother; 2018; 14(10):2472-2477. PubMed ID: 29771601
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence and Determinants Associated with Mumps Antibodies after 20 Years of MMR Vaccination in Urban Area of Shanghai, China.
Pang H; Zhou Y; Zhao W; Jiang Q
Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30249033
[TBL] [Abstract][Full Text] [Related]
18. Australian rubella serosurvey 2012-2013: On track for elimination?
Edirisuriya C; Beard FH; Hendry AJ; Dey A; Gidding HF; Hueston L; Dwyer DE; Wood JG; Macartney KK; McIntyre PB
Vaccine; 2018 May; 36(20):2794-2798. PubMed ID: 29661586
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of rubella infection after national immunization program in Taiwan: vaccination status and immigration impact.
Wang IJ; Huang LM; Chen HH; Hwang KC; Chen CJ
J Med Virol; 2007 Jan; 79(1):97-103. PubMed ID: 17133552
[TBL] [Abstract][Full Text] [Related]
20. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
Miller E; Waight P; Gay N; Ramsay M; Vurdien J; Morgan-Capner P; Hesketh L; Brown D; Tookey P; Peckham C
Commun Dis Rep CDR Rev; 1997 Feb; 7(2):R26-32. PubMed ID: 9046126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
